Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials

Por Hofheinz, R.-D., Ronellenfitsch, U., Kubicka, S., Falcone, A., Burkholder, I., Hacker, U. T.
Publicado no Gastroenterol Res Pract (2016)

Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials

Por Kripp, M., Horisberger, K., Mai, S., Kienle, P., Gaiser, T., Post, S., Wenz, F., Merx, K., Hofheinz, R.-D.
Publicado no Gastroenterol Res Pract (2015)

Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial

Por Ernst, T, Merx, K, Gnad-Vogt, U, Lukan, N, Kripp, M, Schultheis, B, Hochhaus, A, Hofheinz, R-D
Publicado em 2007

Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer

Por Hofheinz, R-D, Willer, A, Weisser, A, Gnad, U, Saussele, S, Kreil, S, Hartmann, J T, Hehlmann, R, Hochhaus, A
Publicado em 2004

Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer

Por Hofheinz, R-D, Heinemann, V, von Weikersthal, L F, Laubender, R P, Gencer, D, Burkholder, I, Hochhaus, A, Stintzing, S
Publicado em 2012

Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial

Por Hofheinz, R-D, Hartmann, J T, Willer, A, Oechsle, K, Hartung, G, Gnad, U, Saussele, S, Kreil, S, Bokemeyer, C, Hehlmann, R, Hochhaus, A
Publicado em 2004

A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer

Por Willeke, F, Horisberger, K, Kraus-Tiefenbacher, U, Wenz, F, Leitner, A, Hochhaus, A, Grobholz, R, Willer, A, Kähler, G, Post, S, Hofheinz, R-D
Publicado em 2007

Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study

Por Hartmann, J T, Oechsle, K, Quietzsch, D, Wein, A, Hofheinz, R D, Honecker, F, Nehls, O, Köhne, C-H, Käfer, G, Kanz, L, Bokemeyer, C
Publicado em 2003

Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial

Por Nehls, O, Oettle, H, Hartmann, J T, Hofheinz, R-D, Hass, H G, Horger, M S, Koppenhöfer, U, Hochhaus, A, Stieler, J, Trojan, J, Gregor, M, Klump, B
Publicado em 2008